Skip to content

Active Secondary Progressive Multiple Sclerosis

Multiple sclerosis is a lifelong condition affecting the brain and spinal cord. Secondary progressive is a phase some people reach after a relapsing remitting course, and active means relapses or new lesions are still occurring within it.

Aubagio

Teriflunomide

14mg

Teriflunomide tablets for relapsing remitting multiple sclerosis. It reduces the overactive immune response that damages nerve fibres in the brain and spinal cord.

From$205.67/ tabletView

Key points

  • Not everyone with relapsing remitting multiple sclerosis progresses to this phase, and the shift can happen gradually.
  • Symptoms can include worsening mobility, fatigue and cognitive changes; management broadly targets the immune system to reduce relapse activity.

Common questions about Active Secondary Progressive Multiple Sclerosis

Which medicines are listed for active secondary progressive multiple sclerosis?

The listed products for this condition contain Teriflunomide, a tablet that modulates the immune system. It is indicated for active secondary progressive multiple sclerosis, as well as relapsing remitting multiple sclerosis and clinically isolated syndrome.

How does active secondary progressive multiple sclerosis differ from relapsing remitting?

In relapsing remitting multiple sclerosis, symptoms flare and then partially or fully improve. In the secondary progressive phase, a gradual worsening of function sets in. The active qualifier means relapses or new lesions are still appearing alongside that decline.

Further reading